Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
PHAXIAM Therapeutics S.A.
PHXMCurrent price
1.66 EUR
+0.06 EUR (+3.74%)
Last closed
1.67 EUR
Company
www.erytech.com
ISIN
FR001400K4B1
Sector
Healthcare
Industry
Biotechnology
Exchange
Euronext Paris
Capitalization
17 592 621 EUR
Yield for 12 month
-61.11 %
1Y
3Y
5Y
10Y
15Y
PHXM
PHAXIAM Therapeutics S.A., a biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States. It develops eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing a portfolio of phages targeting resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections, including staphylococcus aureus, escherichia coli, and pseudomonas aeruginosa. The company was formerly known as ERYTECH Pharma S.A. and changed its name to PHAXIAM Therapeutics S.A. in June 2023. PHAXIAM Therapeutics S.A. was incorporated in 2004 and is headquartered in Lyon, France. Address: 60 Avenue Rockefeller, Lyon, France, 69008
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4.71 EURP/E ratio
–Dividend Yield
–Current Year
+1 323 660 EUR
Last Year
+6 635 267 EUR
Current Quarter
+545 536 EUR
Last Quarter
+545 536 EUR
Current Year
-281 503 EUR
Last Year
+3 732 400 EUR
Current Quarter
+176 188 EUR
Last Quarter
+545 536 EUR
Key Figures PHXM
1 year
3 years
5 years
10 years
EBITDA
-18 864 143 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-25.55 %
PEG Ratio
–
Return On Equity TTM
-95.68 %
Wall Street Target Price
4.71 EUR
Revenue TTM
2 137 221 EUR
Book Value
4.21 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
293.2 %
Dividend Yield
–
Gross Profit TTM
4 172 622 EUR
Earnings per share
-0.98 EUR
Diluted Eps TTM
-0.98 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics PHXM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PHXM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
0.1:1
Payout Ratio
–
Last Split Date
18.09.2023
Dividend Date
–
Stock Valuation PHXM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
8.2315
Enterprise Value EBITDA
1.7997
Price Book MRQ
0.4647
Financials PHXM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PHXM
For 52 weeks
1.5 EUR
4.61 EUR
50 Day MA
1.73 EUR
Shares Short Prior Month
–
200 Day MA
2.53 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart